微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 5.22% | -26.79% | 54.9% | 60/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | 3.37% | -24.61% | 30.12% | 51/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 2.59% | 47.16% | -58.56% | 40/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 6.25% | 47.41% | -12.34% | 50/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 7.13% | 65.43% | 59.51% | 41/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 4.47% | 136.51% | 153.98% | 38/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.76% | 61.47% | -58.49% | 63/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 4.24% | 153.88% | -1.62% | 66/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 4.31% | 167.24% | 128.04% | 69/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.89% | 129.72% | 73.39% | 85/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.09% | 146.58% | 113.85% | 92/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -7.87% | 14.64% | -22.78% | 125/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -6.41% | -499.07% | -0.79% | 127/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -6.36% | -7166.67% | -171.79% | 128/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -2.34% | -490% | 74.62% | 130/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -9.22% | -185.77% | -761.68% | 124/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -1.07% | -108.55% | -1288.89% | 115/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.09% | -98.91% | -85% | 116/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.6% | -89.51% | -94.42% | 104/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 10.75% | -55.63% | -14.14% | 38/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 12.52% | -30.75% | 51.03% | 17/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 8.29% | -4.05% | 44.93% | 23/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 5.72% | 37.83% | -76.39% | 6/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 24.23% | -30.77% | 34.02% | 12/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 18.08% | -35.77% | 109.26% | 7/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 8.64% | -52.61% | 108.19% | 28/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 4.15% | -57.22% | -88.14% | 20/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 35% | -13.98% | 24.33% | 1/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 28.15% | 1366.15% | 54.42% | 1/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 18.23% | 1157.24% | 87.94% | 2/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 9.7% | -19.7% | -76.16% | 1/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 40.69% | 1894.61% | 2019.27% | 1/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 1.92% | 40.15% | 32.41% | 90/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.45% | 222.22% | -88% | 91/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 12.08% | 1648.72% | 492.16% | 1/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 2.04% | 482.86% | 48.91% | 108/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 1.37% | 813.33% | 204.44% | 88/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 0.45% | 152.94% | 157.69% | 97/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | -0.78% | 25.71% | -322.86% | 83/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 0.35% | -91.84% | 133.33% | 103/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 0.15% | -96.72% | 117.65% | 79/159 | 5.7% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | -0.85% | -115.48% | 19.05% | 85/159 | 3.56% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | -1.05% | -127.56% | -124.48% | 77/159 | 2.69% | 贝达药业 | 16.78% | 行业排名> |